FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945851968> ?p ?o ?g. }

• W2945851968 endingPage "370" @default.
• W2945851968 startingPage "273" @default.
• W2945851968 abstract "This chapter describes the general treatment and immune principles and internal management for AECHB and HBV ACLF, including ICU monitoring, general supportive medications/nutrition/nursing, immune therapy, artificial liver supportive systems, hepatocyte/stem cell, and liver transplant, management for special populations, frequently clinical complications and the utilization of Chinese traditional medicines.1.Early clinical indicators of severe hepatitis B include acratia, gastrointestinal symptoms, a daily increase in serum bilirubin >1 mg/dL, toxic intestinal paralysis, bleeding tendency and mild mind anomaly or character change, and the presence of other diseases inducing severe hepatitis. Laboratory indicators include T-Bil, PTA, cholinesterase, pre-albumin and albumin. The roles of immune indicators (such as IL-6, TNF-α, and fgl2), gene polymorphisms, HBV genotypes, and gene mutations as early clinical indicators.2.Intensive Care Unit monitor patients with severe hepatitis include intracranial pressure, infection, blood dynamics, respiratory function, renal function, blood coagulation function, nutritional status and blood purification process. Nursing care should not only include routine care, but psychological and special care (complications).3.Nutrition support and nursing care should be maintained throughout treatment for severe hepatitis. Common methods of evaluating nutritional status include direct human body measurement, creatinine height index (CHI) and subject global assessment of nutrition (SGA). Malnourished patients should receive enteral or parenteral nutrition support.4.Immune therapies for severe hepatitis include promoting hepatocyte regeneration (e.g. with glucagon, hepatocyte growth factor and prostaglandin E1), glucocorticoid suppressive therapy, and targeting molecular blocking. Corticosteroid treatment should be early and sufficient, and adverse drug reactions monitored. Treatments currently being investigated are those targeting Toll-like receptors, NK cell/NK cell receptors, macrophage/immune coagulation system, CTLA-4/PD-1 and stem cell transplantation.5.In addition to conventional drugs and radioiodine, corticosteroids and artificial liver treatment can also be considered for severe hepatitis patients with hyperthyreosis. Patients with gestational severe hepatitis require preventive therapy for fetal growth restriction, and it is necessary to choose the timing and method of fetal delivery. For patients with both diabetes and severe hepatitis, insulin is preferred to oral antidiabetic agents to control blood glucose concentration. Liver toxicity of corticosteroids and immune suppressors should be monitored during treatment for severe hepatitis in patients with connective tissue diseases including SLE, RA and sicca syndrome. Patient with connective tissue diseases should preferably be started after the antiviral treatment with nucleos(t)ide analogues.6.An artificial liver can improve patients’ liver function; remove endotoxins, blood ammonia and other toxins; correct amino acid metabolism and coagulation disorders; and reverse internal environment imbalances. Non-bioartificial livers are suitable for patients with early and middle stage severe hepatitis; for late-stage patients waiting for liver transplantation; and for transplanted patients with rejection reaction or transplant failure. The type of artificial liver should be determined by each patient’s condition and previous treatment purpose, and patients should be closely monitored for adverse reactions and complications. Bio- and hybrid artificial livers are still under development.7.MELD score is the international standard for choosing liver transplantation. Surgical methods mainly include the in situ classic type and the piggyback type; transplantation includes no liver prophase, no liver phase or new liver phase. Preoperative preparation, management of intraoperative and postoperative complications and postoperative long-term treatment are keys to success.8.Severe hepatitis belongs to the categories of “acute jaundice”, “scourge jaundice”, and “hot liver” in traditional Chinese medicine. Treatment methods include Chinese traditional medicines, acupuncture and acupoint injection, external application of drugs, umbilical compress therapy, drip, blow nose therapy, earpins, and clysis. Dietary care is also an important part of traditional Chinese medicine treatment." @default.
• W2945851968 created "2019-05-29" @default.
• W2945851968 creator A5005634485 @default.
• W2945851968 creator A5027860138 @default.
• W2945851968 creator A5041462354 @default.
• W2945851968 creator A5045355806 @default.
• W2945851968 creator A5045392886 @default.
• W2945851968 creator A5047436259 @default.
• W2945851968 creator A5057422995 @default.
• W2945851968 creator A5064191581 @default.
• W2945851968 creator A5066251595 @default.
• W2945851968 date "2019-01-01" @default.
• W2945851968 modified "2023-10-16" @default.
• W2945851968 title "Treatment of AECHB and Severe Hepatitis (Liver Failure)" @default.
• W2945851968 cites W1493149511 @default.
• W2945851968 cites W1526097236 @default.
• W2945851968 cites W1532605623 @default.
• W2945851968 cites W1537863311 @default.
• W2945851968 cites W1542964065 @default.
• W2945851968 cites W1686058237 @default.
• W2945851968 cites W1692461747 @default.
• W2945851968 cites W1812232001 @default.
• W2945851968 cites W1861823359 @default.
• W2945851968 cites W1891684625 @default.
• W2945851968 cites W1892110922 @default.
• W2945851968 cites W1897035203 @default.
• W2945851968 cites W1926565507 @default.
• W2945851968 cites W1937654413 @default.
• W2945851968 cites W1948254390 @default.
• W2945851968 cites W1963040710 @default.
• W2945851968 cites W1964555364 @default.
• W2945851968 cites W1968737141 @default.
• W2945851968 cites W1969400745 @default.
• W2945851968 cites W1970006771 @default.
• W2945851968 cites W1970617924 @default.
• W2945851968 cites W1971200468 @default.
• W2945851968 cites W1973475710 @default.
• W2945851968 cites W1974898516 @default.
• W2945851968 cites W1978745104 @default.
• W2945851968 cites W1979785204 @default.
• W2945851968 cites W1980672296 @default.
• W2945851968 cites W1980942611 @default.
• W2945851968 cites W1982692107 @default.
• W2945851968 cites W1984254868 @default.
• W2945851968 cites W1987826457 @default.
• W2945851968 cites W198903736 @default.
• W2945851968 cites W1993065115 @default.
• W2945851968 cites W1993844738 @default.
• W2945851968 cites W1994391878 @default.
• W2945851968 cites W1996002435 @default.
• W2945851968 cites W1996033534 @default.
• W2945851968 cites W1999138823 @default.
• W2945851968 cites W1999889167 @default.
• W2945851968 cites W2000551398 @default.
• W2945851968 cites W2000987876 @default.
• W2945851968 cites W2001104440 @default.
• W2945851968 cites W2002696889 @default.
• W2945851968 cites W2003405831 @default.
• W2945851968 cites W2003831877 @default.
• W2945851968 cites W2004072697 @default.
• W2945851968 cites W2004385043 @default.
• W2945851968 cites W2004709015 @default.
• W2945851968 cites W2004803235 @default.
• W2945851968 cites W2007258272 @default.
• W2945851968 cites W2007853662 @default.
• W2945851968 cites W2007873773 @default.
• W2945851968 cites W2008365696 @default.
• W2945851968 cites W2010102037 @default.
• W2945851968 cites W2010461682 @default.
• W2945851968 cites W2010575617 @default.
• W2945851968 cites W2011290357 @default.
• W2945851968 cites W2012490495 @default.
• W2945851968 cites W2015040751 @default.
• W2945851968 cites W2018206475 @default.
• W2945851968 cites W2018393234 @default.
• W2945851968 cites W2018497025 @default.
• W2945851968 cites W2019229253 @default.
• W2945851968 cites W2021037639 @default.
• W2945851968 cites W2021246809 @default.
• W2945851968 cites W2023299094 @default.
• W2945851968 cites W2025966264 @default.
• W2945851968 cites W2027230796 @default.
• W2945851968 cites W2029377130 @default.
• W2945851968 cites W2029773497 @default.
• W2945851968 cites W2030748531 @default.
• W2945851968 cites W2031857661 @default.
• W2945851968 cites W2032144623 @default.
• W2945851968 cites W2032180141 @default.
• W2945851968 cites W2032271353 @default.
• W2945851968 cites W2033490528 @default.
• W2945851968 cites W2033831723 @default.
• W2945851968 cites W2034394906 @default.
• W2945851968 cites W2034964537 @default.
• W2945851968 cites W2035966867 @default.
• W2945851968 cites W2037190876 @default.
• W2945851968 cites W2038324131 @default.
• W2945851968 cites W2039514520 @default.
• W2945851968 cites W2039571676 @default.

• next